Johnson & Johnson (JNJ) Company Profile
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in Ne w Brunswick, New Jersey.
News about JNJ
AARP Thanks Congress For "Modest" Omnibus Bill Increases
&l;p&g;America&a;rsquo;s largest special interest group for Americans over 50&a;mdash;&l;a href=&q;https://www.aarp.org/?intcmp=GLBNAV-PL-HOME-HOME&q; target=&q;_blank&q;&g;AARP&l;/a&g;&a;mdash;is praising the actions of President Donald Trump and Co...Read More>>>
AstraZeneca Looks To Prove Itself In The Type 2 Diabetes Market
Recently, AstraZeneca (AZN) announced positive results from its phase 3 study. The company used its drug dapagliflozin marketed as FARXIGA to treat patients with type 2 diabetes ((T2D)) with moderate renal impairment (chronic kidney disease). The rea...Read More>>>
This Is Why The Venezuela Cryptocurrency Matters
&l;p&g;Fiat digital coins are coming. And the concept is just as clunky as the name.This week, President Trump banned deals in the Venezuela Petro, a cryptocurrency backed by crude oil.The Petro speaks volumes about Venezuelan finances. It also sound...Read More>>>
The No BS Plan Report, Week 5: Does Sideways Movement Mean An Imminent Inflection Point?
Author's note: As always, I'm happy to answer questions in the comments below, but you can get direct access to me in the Total Pharma Tracker chatroom if you want to discuss in further detail! Spoiler alert: Week 5 was fairly boring in terms of trad...Read More>>>
Get Ready, 5G is Going To Change Everything
&l;p&g;Wireless networks 20 times faster are just around the corner.In January,&a;nbsp;&l;strong&g;Qualcomm&l;/strong&g;&a;nbsp;(QCOM)&a;nbsp;&l;a href=&q;https://mandrillapp.com/track/click/30905169/www.qualcomm.com?p=eyJzIjoiRC1kSVVjWHNtV0xuVmxGY0F...Read More>>>